
Loading, please wait...

Loading, please wait...

G-protein-coupled receptors (GPCRs) act as major pathways for signals from neurotransmitters like epinephrine and acetylcholine. However, mapping these signals at high resolution throughout the brain has traditionally been difficult. Therefore, researchers developed the SENSIT platform GPCR ligands sensor to solve this challenge. This tool uses chimeric nanobodies to detect chemical release events across large volumes. In addition, it integrates these signals over time for better visualization and whole-brain mapping.
The platform shows excellent selectivity for specific molecules like epinephrine and norepinephrine. For example, it distinguishes epinephrine from other catecholamines with 20-fold selectivity. Furthermore, its modular design allows for the creation of various other sensors, such as those for the muscarinic acetylcholine receptor 2. Consequently, this technology might enable the first detailed maps of diverse neurotransmitter pathways. Because it is a single-chain integrator, the system is easier for researchers to express in various neural environments. This versatility makes it a promising tool for future neuroscience applications.
The SENSIT platform is a modular, single-chain fluorescent integrator used to map neurotransmitter activity in the brain with high resolution.
They offer high selectivity, such as a 20-fold preference for epinephrine over norepinephrine, which ensures highly accurate chemical mapping.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Putansu A et al. SENSIT, a Modular Single-Chain Fluorescent Integrator Platform for GPCR Ligands. ACS Chem Biol. 2026 Jun 08. doi: 10.1021/acschembio.6c00161. PMID: 42258302.
Kroning KE et al. Single-chain fluorescent integrators for mapping G-protein-coupled receptor agonists. Proc Natl Acad Sci U S A. 2024;121(18):e2307090121.
Skiniotis G. Structural findings reveal how distinct GPCR ligands create different levels of activation. Nature. 2025.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


SENSIT is a modular single-chain integrator platform designed to detect and map GPCR ligands like epinephrine and acetylcholine with high resolution....
3 months ago

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today